Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karen Owen

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Managed Care Quarterly|June 7, 2003
Legal perspectives from Sidley Austin Brown & Wood LLP memo from investors: we're watching the cost of complying with HIPAAKaren Owen Dunlop
Leadership in Health Services (Bradford, England)|May 18, 2018
EditorialGraham Dickson, Karen Owen
Leadership in Health Services (Bradford, England)|July 12, 2016
EditorialGraham Dickson, Karen Owen
Investigational New Drugs|August 5, 2010
A Phase II trial of 17-allylamino, 17-demethoxygeldanamycin (17-AAG, tanespimycin) in patients with metastatic melanomaSimon Pacey, Martin Gore, David Chao, et al.
Heart, Lung & Circulation|September 19, 2017
Validation of the RETRIEVE (REverse TRIage EVEnts) Criteria for Same Day Return of Non-ST Elevation Acute Coronary Syndrome Patients to Referring Non-PCI CentresSonya N Burgess, Vu Huynh Nguyen, James Xu, et al.
Transplantation|October 27, 2009
A phase I trial of epstein-barr virus gp350 vaccine for children with chronic kidney disease awaiting transplantationLesley Rees, E Jane Tizard, Andrew J Morgan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2009
A phase I trial of radioimmunotherapy with 131I-A5B7 anti-CEA antibody in combination with combretastatin-A4-phosphate in advanced gastrointestinal carcinomasTim Meyer, Andrew M Gaya, Gairin Dancey, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Managed Care Quarterly|June 7, 2003
Legal perspectives from Sidley Austin Brown & Wood LLP memo from investors: we're watching the cost of complying with HIPAAKaren Owen Dunlop
Leadership in Health Services (Bradford, England)|May 18, 2018
EditorialGraham Dickson, Karen Owen
Leadership in Health Services (Bradford, England)|July 12, 2016
EditorialGraham Dickson, Karen Owen
Investigational New Drugs|August 5, 2010
A Phase II trial of 17-allylamino, 17-demethoxygeldanamycin (17-AAG, tanespimycin) in patients with metastatic melanomaSimon Pacey, Martin Gore, David Chao, et al.
Heart, Lung & Circulation|September 19, 2017
Validation of the RETRIEVE (REverse TRIage EVEnts) Criteria for Same Day Return of Non-ST Elevation Acute Coronary Syndrome Patients to Referring Non-PCI CentresSonya N Burgess, Vu Huynh Nguyen, James Xu, et al.
Transplantation|October 27, 2009
A phase I trial of epstein-barr virus gp350 vaccine for children with chronic kidney disease awaiting transplantationLesley Rees, E Jane Tizard, Andrew J Morgan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2009
A phase I trial of radioimmunotherapy with 131I-A5B7 anti-CEA antibody in combination with combretastatin-A4-phosphate in advanced gastrointestinal carcinomasTim Meyer, Andrew M Gaya, Gairin Dancey, et al.
Pageof 1